# 2025-02732: Mylan Gets Green Light for Super-Painkiller Imports

2025-02732, Importer of Controlled Substances Application: Mylan Pharmaceuticals, Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-02-18, effective Registered bulk manufacturers of the affected basic class(es), and applicants may submit electronic comments or objections on or before March 20, 2025. Such persons may also file a written request for a hearing on the application on or before March 20, 2025. (as of 2026-09-24).

- Canonical: https://policyrisk.com/federal-register/2025-02732
- As of: 2026-09-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-02732
- Title: Importer of Controlled Substances Application: Mylan Pharmaceuticals, Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 9732
- Published: 2025-02-18
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants may submit electronic comments or objections on or before March 20, 2025. Such persons may also file a written request for a hearing on the application on or before March 20, 2025.
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-09-24

## In one line

Mylan Gets Green Light for Super-Painkiller Imports

## Summary

Mylan Pharmaceuticals wants to become an official importer of a strong painkiller called Remifentanil. This affects drug makers and anyone interested in controlled substances, who can share their thoughts or ask for a hearing by March 20, 2025. No costs or fees are mentioned, but the decision could impact how this drug enters the U.S. market.

## Abstract

Mylan Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-02732 on federalregister.gov](https://www.federalregister.gov/documents/2025/02/18/2025-02732/importer-of-controlled-substances-application-mylan-pharmaceuticals-inc)
- [2025-02732 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-02-18/pdf/2025-02732.pdf)

## Related
- [Previous: 2025-02731, Bulk Manufacturer of Controlled Substances Application: Purisys, LLC](https://policyrisk.com/federal-register/2025-02731)
- [Next: 2025-02733, Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Ins…](https://policyrisk.com/federal-register/2025-02733)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-02732 (as of 2026-09-24).
